Vaccines, Blood & Biologics

Compliance Actions (Biologics)

CBER carries out a wide range of compliance and surveillance activities during the "life cycle" of biological products, including:

  • Conducting pre-license and pre-approval inspections of manufacturing facilities and products under clinical study.
  • Monitoring the safety, purity and potency of biological products through review of:
    • Biological Product Deviation Reports (BPDRs) and HCT/P Deviation Reports,
    • Investigations into transfusion and donation related fatalities and other adverse events,
    • Product recalls.
  • Monitoring reports of biological product shortages.
  • Initiating regulatory action to address non-compliance with FDA laws and regulations.
  • Monitoring of research conducted on biological products and assessing the protection of the rights, safety, and welfare of human research subjects and the quality and integrity of research data.
  • Monitoring import and export activities.
  • Reviewing product advertising and promotional labeling.

Recalls

Product Safety & Availability

Administrative Actions Issued By CBER

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 04/20/2011
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.